Literature DB >> 15610072

Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodelling and glomeruli loss in spontaneously hypertensive rats.

Daniele G Bezerra1, Carlos A Mandarim-de-Lacerda.   

Abstract

The aim of the present study was to investigate the possibility of different effects of the hydrophobic statin simvastatin and the hydrophilic statin pravastatin on the remodelling process in the overloaded left ventricle and renal cortex of SHRs (spontaneously hypertensive rats). Fifteen SHRs were treated for 40 days with simvastatin, pravastatin or placebo (water) via orogastric administration. Left ventricle and renal cortex were examined by light microscopy and stereology. LV (left ventricular) cardiomyocyte nuclei (N[cmn]) and glomeruli (N[gl]) numbers were estimated by the dissector method. BP (blood pressure) and serum triacylglycerols (triglycerides) were lower in the statin-treated groups than in the untreated control group. The volume density of the interstitial connective tissue was smaller and length density of the intramyocardial arteries, as well as the arteries/cardiomyocyte ratio, was greater in the statin-treated groups than in the control group. No difference was observed between the two statin-treated groups. The cross-sectional cardiomyocyte area was significantly smaller in the simvastatin-treated group than in the control or pravastatin-treated groups, and it was smaller in the pravastatin-treated group than in the control group. N[cmn] and N[gl] were greater in the two statin-treated groups than in the control group, but no significant difference was observed between the two statin-treated groups. In conclusion, administration of the statins simvastatin and pravastatin to SHRs effectively prevented the elevation in BP and serum triaclyglycerols, and also attenuated adverse cardiac and kidney remodelling by preventing LV hypertrophy, enhancing myocardial vascularization with the decrease in interstitial fibrosis and attenuating cardiomyocyte and glomerular loss.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15610072     DOI: 10.1042/CS20040292

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  4 in total

1.  Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation.

Authors:  Wen-Han Cheng; Wen-Yu Ho; Chien-Feng Chang; Pei-Jung Lu; Pei-Wen Cheng; Tung-Chen Yeh; Ling-Zong Hong; Gwo-Ching Sun; Michael Hsiao; Ching-Jiunn Tseng
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

2.  Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.

Authors:  Sarah F Knight; Jianghe Yuan; Siddhartha Roy; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

3.  Effect of simvastatin on culturing of kidney cells from pigs in vitro.

Authors:  Guifen Liu; Haichao Lin; Jinlian Fu; Aiguo Wang
Journal:  Mol Biol Rep       Date:  2009-04-03       Impact factor: 2.316

4.  Pravastatin normalises peripheral cardiac sympathetic hyperactivity in the spontaneously hypertensive rat.

Authors:  Neil Herring; Chee Wan Lee; Nicholas Sunderland; Kathryn Wright; David J Paterson
Journal:  J Mol Cell Cardiol       Date:  2010-10-08       Impact factor: 5.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.